IR vs IRD · P/E 49, rev $7.24B vs rev $11.0M
Ingersoll Rand Inc (IR) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. IRD currently screens at market cap $35.7M.
Not investment advice. Open the IR and IRD stock pages for the full models.
Not investment advice.